Antibody Protein ELISA Kit from MyBioSource header Telephone 1.858.633.0165          
1.855.MyBioSource
Fax 1.858.633.0166    Email sales@mybiosource.com 
tel/fax
menu1 Home Products Ordering Company Help menu7
bottom
   MyBioSource rightarrow Antibody rightarrow APOE  rightarrow LOG IN  rightarrow MY ACCOUNT  rightarrow CART CONTENTS  rightarrow CHECKOUT 
horiz bar
MyBioSource Menu separator
separator
ELISA Kit ELISA Kit
CLIA Kit CLIA Kit
PCR Kit PCR Kit
Monoclonal Antibody Monoclonal Antibody
Polyclonal Antibody Polyclonal Antibody
Secondary Antibody Secondary Antibody
Antigen Antigen
Biochemical Biochemical
cDNA Clone cDNA Clone
siRNA siRNA
Peptide Peptide
Recombinant/Purified Protein Rec./Purified Protein

Custom ELISA Kit Custom ELISA Kit
Custom Protein Custom Protein
Custom Antibody Custom Antibody
Antibody Matched Pairs Antibody Matched Pairs
Antibody & Corresponding Blocking Peptide Pairs Antibody Peptide Pairs
Phospho-Specific Antibodies Phospho Antibodies
Products by Disease Products by Disease
Products by Pathway Products by Pathway
Products by Tissue Products by Tissue

arrow Advanced Search
arrow Submit Technical Q&A
arrow International Distributors
arrow Contact Us
separator
Our Best Sellers moreseparator
separator
 • LATH Antibody
 • PAK1 (Phospho-Ser204) Antibody
 • Pin1 (Phospho-Ser16) Antibody
 • Mannose Binding Lectin C (MBL-C) ELISA Kit
 • Selenoprotein P1, Plasma (SEPP1) ELISA Kit
 • A Disintegrin and Metalloprotease 2 (ADAM2) ELISA Kit
 • Sperm Protein 17 (SP17) ELISA Kit
 • Cluster of Differentiation 8 (CD8) ELISA Kit
 • Deubiquitinating Enzyme (DUB) ELISA Kit
 • 3-Methyl Noradrenaline (3MNADR) ELISA Kit
 • Fetuin A (FETU-A) ELISA Kit
 • Hepatocyte Nuclear Factor 1 Alpha (HNF1alpha) ELISA Kit
 • Protein Kinase, Amp Activated Alpha 1 (PRKAA1) ELISA Kit
 • Angiotensin 2 Receptor Type 2 Autoantibodies (AGTR2-AA) ELISA Kit
 downarrow more ...
separator
separator
DatasheetFull DatasheetPrinter Friendly DatasheetPrint This DatasheetAdd to Compare ListHave Questions? Ask UsRequest for a Quotation today

anti-APOE antibody :: Goat Apolipoprotein E Antibody

Scan QR to view Datasheet Catalog #    MBS686029
SDS-PAGE
Unit / Price
1 mg  /  $280 +1 FREE 8GB USB
 
 Go to:   rightarrow  Product Names   rightarrow Product Info   rightarrow Accession #s   rightarrow Product Desc   rightarrow Diseases/Tissues/Pathways   rightarrow Applications   rightarrow References 
 Product Name   

Apolipoprotein E (APOE), Antibody

 Also Known As   

Goat anti-Apolipoprotein E - Affinity Pure

 Product Gene Name   

anti-APOE antibody

[Similar Products]
 Research Use Only    For Research Use Only. Not for use in diagnostic procedures.
Table BarTOPTable Bar
 OMIM    M12529 mRNA
Section Bar
 Host    Goat
 Species Reactivity    Apolipoprotein E
Section Bar
 Specificity    Human Apolipoprotein E
 Purity/Purification    > 95% based on SDS-PAGE
Affinity purified using solid phase Human Apolipoprotein E.
 Form/Format    Clear, colorless liquid, 0.2 um filtered
 Concentration    > 4.5 mg/ml (E 1% at 280 nm = 13.0) (lot specific)
Section Bar
 Conjugate    UnConjugated
 Immunogen    Human Apolipoprotein E
 Buffer    10 mM Sodium Phosphate, 0.15 M Sodium Chloride, pH 7.2
 Preservative    0.05% (w/v) Sodium Azide
 Country of Origin    Goat serum was obtained from healthy animals of US origin and under the care of a registered veterinarian.
Section Bar
 Preparation and Storage    Store at 2-8 degree C
 Other Notes    Small volumes of anti-APOE antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
 Searchable Terms for APOE purchase    With the increasing correlation between cholesterol and Alzheimer Disease, cholesterol transporting proteins like the apolipoprotein family, typified by ApoE, are the subject of multiple studies. The addition of a goat anti apolipoprotein 3 antibody to previously cataloged mouse or rat monoclonal antibody or rabbit polyclonal ApoE primary antibodies allows more flexible detection by western blot, ELISA or IHC since anti goat rabbit IgG Alexa fluorâ® or Alexa 174 fluor secondary antibodies may be used as reagents. This ApoE polyclonal antibody production was sourced from US human peptide immunized serum and is ideal for cell lysate analysis, metabolism related studies of cholesterol transport or custom applications. Anti ApoE antibody is species reactivity human specific, non-reactive to protein family members and validated by WB in protein lysates, included in the product datasheet. Other apolipoprotein antibody products, custom antibody production for protein family antibodies in this products category and related reagents are available.
Table BarTOPTable Bar
 Product Categories/Family for anti-APOE antibody    Primary Antibodies
 Applications Tested/Suitable for anti-APOE antibody   

Western Blot (WB), ELISA (EIA)

Section Bar
 SDS-PAGE of anti-APOE antibody    Appearance: Clear, colorless liquid
Purity: Two predominant bands at 50 and 24 kDa based on SDS-PAGE
1) MBS686029, Lot # 5-130-111907
2) Mol Weight Standard
anti-APOE antibody SDS-PAGE image
Table BarTOPTable Bar
NCBI/Uniprot data below describe general gene information for APOE. It may not necessarily be applicable to this product.
 NCBI GI #    178853
 NCBI GeneID    348
 NCBI Accession #    AAB59397 [Other Products]
Section Bar
 UniProt Secondary Accession #    Q9P2S4; B2RC15; C0JYY5 [Other Products]
 UniProt Related Accession #    P02649 [Other Products]
 Molecular Weight    36,154 Da [Similar Products]
Table BarTOPTable Bar
 NCBI Official Full Name    apolipoprotein E
 NCBI Official Synonym Full Names    apolipoprotein E
 NCBI Official Symbol    APOE [Similar Products]
 NCBI Official Synonym Symbols   
AD2; LPG; APO-E; ApoE4; LDLCQ5
[Similar Products]
 NCBI Protein Information    apolipoprotein E
 UniProt Protein Name    Apolipoprotein E
 Protein Family    Apolipoprotein
 UniProt Gene Name    APOE [Similar Products]
 UniProt Synonym Gene Names    Apo-E [Similar Products]
Section Bar
 NCBI Summary for APOE    The protein encoded by this gene is a major apoprotein of the chylomicron. It binds to a specific liver and peripheral cell receptor, and is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. This gene maps to chromosome 19 in a cluster with the related apolipoprotein C1 and C2 genes. Mutations in this gene result in familial dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III), in which increased plasma cholesterol and triglycerides are the consequence of impaired clearance of chylomicron and VLDL remnants. [provided by RefSeq, Jun 2016]
Section Bar
 UniProt Comments for APOE    APOE: Mediates the binding, internalization, and catabolism of lipoprotein particles. It can serve as a ligand for the LDL (apo B/E) receptor and for the specific apo-E receptor (chylomicron remnant) of hepatic tissues. Defects in APOE are a cause of hyperlipoproteinemia type 3 (HLPP3); also known as familial dysbetalipoproteinemia. Individuals with HLPP3 are clinically characterized by xanthomas, yellowish lipid deposits in the palmar crease, or less specific on tendons and on elbows. The disorder rarely manifests before the third decade in men. In women, it is usually expressed only after the menopause. The vast majority of the patients are homozygous for APOE*2 alleles. More severe cases of HLPP3 have also been observed in individuals heterozygous for rare APOE variants. The influence of APOE on lipid levels is often suggested to have major implications for the risk of coronary artery disease (CAD). Individuals carrying the common APOE*4 variant are at higher risk of CAD. Genetic variations in APOE are associated with Alzheimer disease type 2 (AD2). It is a late-onset neurodegenerative disorder characterized by progressive dementia, loss of cognitive abilities, and deposition of fibrillar amyloid proteins as intraneuronal neurofibrillary tangles, extracellular amyloid plaques and vascular amyloid deposits. The major constituent of these plaques is the neurotoxic amyloid-beta-APP 40-42 peptide (s), derived proteolytically from the transmembrane precursor protein APP by sequential secretase processing. The cytotoxic C-terminal fragments (CTFs) and the caspase-cleaved products such as C31 derived from APP, are also implicated in neuronal death. The APOE*4 allele is genetically associated with the common late onset familial and sporadic forms of Alzheimer disease. Risk for AD increased from 20% to 90% and mean age at onset decreased from 84 to 68 years with increasing number of APOE*4 alleles in 42 families with late onset AD. Thus APOE*4 gene dose is a major risk factor for late onset AD and, in these families, homozygosity for APOE*4 was virtually sufficient to cause AD by age 80. The mechanism by which APOE*4 participates in pathogenesis is not known. Defects in APOE are a cause of sea-blue histiocyte disease (SBHD); also known as sea-blue histiocytosis. This disorder is characterized by splenomegaly, mild thrombocytopenia and, in the bone marrow, numerous histiocytes containing cytoplasmic granules which stain bright blue with the usual hematologic stains. The syndrome is the consequence of an inherited metabolic defect analogous to Gaucher disease and other sphingolipidoses. Defects in APOE are a cause of lipoprotein glomerulopathy (LPG). LPG is an uncommon kidney disease characterized by proteinuria, progressive kidney failure, and distinctive lipoprotein thrombi in glomerular capillaries. It mainly affects people of Japanese and Chinese origin. The disorder has rarely been described in Caucasians. Belongs to the apolipoprotein A1/A4/E family.

Protein type: Lipid-binding; Secreted; Secreted, signal peptide

Chromosomal Location of Human Ortholog: 19q13.32

Cellular Component: chylomicron; cytoplasm; early endosome; endoplasmic reticulum; extracellular matrix; extracellular region; extracellular space; Golgi apparatus; membrane; nucleus; plasma membrane

Molecular Function: antioxidant activity; beta-amyloid binding; cholesterol binding; cholesterol transporter activity; heparin binding; identical protein binding; lipid binding; lipid transporter activity; low-density lipoprotein receptor binding; metal chelating activity; phospholipid binding; protein binding; protein homodimerization activity; tau protein binding

Biological Process: cGMP-mediated signaling; cholesterol catabolic process; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cytoskeleton organization and biogenesis; fatty acid homeostasis; G-protein coupled receptor protein signaling pathway; intracellular transport; lipoprotein catabolic process; lipoprotein metabolic process; long-chain fatty acid transport; negative regulation of blood coagulation; negative regulation of blood vessel endothelial cell migration; negative regulation of cholesterol biosynthetic process; negative regulation of endothelial cell proliferation; negative regulation of inflammatory response; negative regulation of MAP kinase activity; negative regulation of neuron apoptosis; neurite regeneration; nitric oxide mediated signal transduction; phospholipid efflux; positive regulation of cGMP biosynthetic process; positive regulation of lipid biosynthetic process; positive regulation of low-density lipoprotein receptor catabolic process; positive regulation of membrane protein ectodomain proteolysis; positive regulation of nitric-oxide synthase activity; protein import; receptor-mediated endocytosis; regulation of axon extension; regulation of Cdc42 protein signal transduction; regulation of neuronal synaptic plasticity; retinoid metabolic process; reverse cholesterol transport; synaptic transmission, cholinergic; triacylglycerol catabolic process; triacylglycerol metabolic process; virus assembly

Disease: Alzheimer Disease 2; Alzheimer Disease 4; Lipoprotein Glomerulopathy; Macular Degeneration, Age-related, 1; Sea-blue Histiocyte Disease
Table BarTOPTable Bar
 Research Articles on APOE    1. Study suggested that conventional criteria for Mild Cognitive Impairment may be susceptible to false positive diagnostic errors, and that onset of Abeta accumulation may occur earlier in APOE varepsilon4 carriers compared to non-carriers
Table BarTOPTable Bar
 Precautions    All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
 Disclaimer    While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Table BarTOPTable Bar
Products associated with anti-APOE antibodyPathways associated with anti-APOE antibody
 Reference Product  PubMed Publications
 APOB antibody  >1469 publications with APOE and APOB
 LDLR antibody  >543 publications with APOE and LDLR
 LPL antibody  >322 publications with APOE and LPL
 SCARB1 antibody  >112 publications with APOE and SCARB1
 MAPT antibody  >103 publications with APOE and MAPT
 LRP1 antibody  >74 publications with APOE and LRP1
 APOC3 antibody  >73 publications with APOE and APOC3
 VLDLR antibody  >52 publications with APOE and VLDLR
 LIPC antibody  >41 publications with APOE and LIPC
 LRP8 antibody  >15 publications with APOE and LRP8
 Products by Pathway  Pathway Diagram
 Alzheimer's Disease Pathway antibodies  Alzheimer's Disease Pathway Diagram
 Alzheimer's Disease Pathway antibodies  Alzheimer's Disease Pathway Diagram
 Alzheimers Disease Pathway antibodies  Alzheimers Disease Pathway Diagram
 Binding And Uptake Of Ligands By Scavenger Receptors Pathway antibodies  Binding And Uptake Of Ligands By Scavenger Receptors Pathway Diagram
 Chylomicron-mediated Lipid Transport Pathway antibodies  Chylomicron-mediated Lipid Transport Pathway Diagram
 Disease Pathway antibodies  Disease Pathway Diagram
 Diseases Associated With Visual Transduction Pathway antibodies  Diseases Associated With Visual Transduction Pathway Diagram
 HDL-mediated Lipid Transport Pathway antibodies  HDL-mediated Lipid Transport Pathway Diagram
 Lipid Digestion, Mobilization, And Transport Pathway antibodies  Lipid Digestion, Mobilization, And Transport Pathway Diagram
 Lipoprotein Metabolism Pathway antibodies  Lipoprotein Metabolism Pathway Diagram
Diseases associated with anti-APOE antibodyOrgans/Tissues associated with anti-APOE antibody
 Disease Name  Pubmed Publications
 Cardiovascular Diseases Antibodies  >6002 publications with APOE and Cardiovascular Diseases
 Alzheimer Disease Antibodies  >5588 publications with APOE and Alzheimer Disease
 Atherosclerosis Antibodies  >4765 publications with APOE and Atherosclerosis
 Arteriosclerosis Antibodies  >3967 publications with APOE and Arteriosclerosis
 Hyperlipidemias Antibodies  >1801 publications with APOE and Hyperlipidemias
 Inflammation Antibodies  >1582 publications with APOE and Inflammation
 Cognition Disorders Antibodies  >1341 publications with APOE and Cognition Disorders
 Plaque, Atherosclerotic Antibodies  >1203 publications with APOE and Plaque, Atherosclerotic
 Coronary Disease Antibodies  >1120 publications with APOE and Coronary Disease
 Hypercholesterolemia Antibodies  >1036 publications with APOE and Hypercholesterolemia
 Organ/Tissue Name  Pubmed Publications
 Brain Antibodies  >4300 publications with APOE and Brain
 Vascular Antibodies  >4046 publications with APOE and Vascular
 Liver Antibodies  >1858 publications with APOE and Liver
 Heart Antibodies  >1565 publications with APOE and Heart
 Muscle Antibodies  >1179 publications with APOE and Muscle
 Nerve Antibodies  >623 publications with APOE and Nerve
 Bone Antibodies  >575 publications with APOE and Bone
 Kidney Antibodies  >501 publications with APOE and Kidney
 Lung Antibodies  >267 publications with APOE and Lung
 Spleen Antibodies  >230 publications with APOE and Spleen
Table BarTOPTable Bar
horiz bar
 SSL   Follow us on Facebook Follow us onTwitter Follow us on Google Plus Connect us on LinkedIn Subscribe to our RSS Feed for latest products and special promotions